Famciclovir patent dispute in Korea

Published: 2004-08-09 06:57:00

Updated: 2004-08-09 06:57:00

Novaris's Korean subsidiary, Novartis Korea, has initiated legal action against Kyungdong Pharm, which is commercializing generic version of its antiviral agent, Famvir (famciclovir). The suit, which was filed to the Suwon District Court on August 5, alleges Kyungdong's potential infringement of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK